Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN1 | Q9GZT9 | 12/20 | 0.47 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.42 |
| ▸ | ASPH | Q12797 | 1/20 | 0.42 |
| ▸ | KDM8 | Q8N371 | 1/20 | 0.42 |
| ▸ | EGLN3 | Q9H6Z9 | 2/20 | 0.40 |
| ▸ | VEGFA | P15692 | 1/20 | 0.40 |
| ▸ | FLT1 | P17948 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 2/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | NAPEPLD | Q6IQ20 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | XDH | P47989 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8520898 | 0.86 | EGLN1 (0.42) | EGLN1PKM | |
| SCHEMBL8520900 | 0.82 | EGLN1 (0.43) | EGLN1BBOX1ASPHKDM8 | |
| Hydrochloric Acid SCHEMBL21403277 | 0.81 | EGLN1 (0.44) | EGLN1BBOX1ASPHKDM8 | |
| SCHEMBL12828564 | 0.81 | EGLN1 (0.50) | EGLN1BBOX1ASPHKDM8HPGD | |
| SCHEMBL21403271 | 0.79 | EGLN1 (0.41) | EGLN1BBOX1ASPHKDM8 | |
| Enarodustat SCHEMBL1481440 | 0.79 | EGLN1 (0.64) | EGLN1BBOX1ASPHKDM8EGLN3 | |
| Enarodustat SCHEMBL21403279 | 0.78 | EGLN1 (0.63) | EGLN1BBOX1ASPHKDM8EGLN3 | |
| Enarodustat SCHEMBL1481939 | 0.78 | EGLN1 (0.65) | EGLN1BBOX1ASPHKDM8EGLN3 | |
| SCHEMBL8527866 | 0.76 | EGLN1 (0.47) | EGLN1BBOX1ASPHKDM8HPGD | |
| Enarodustat SCHEMBL21403278 | 0.76 | EGLN1 (0.53) | EGLN1BBOX1ASPHKDM8EGLN3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122036723-A | Enalidomide Key intermediate and application thereof | 迪嘉药业集团股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-11434238-B2 | Method for producing triazolopyridine compound | JAPAN TOBACCO INC. (JP) | 2022-09-06 | — | — | US | disclosed |
| US-20200339563-A1 | METHOD FOR PRODUCING TRIAZOLOPYRIDINE COMPOUND | SHIONOGI & CO., LTD. (JP) | 2020-10-29 | — | — | US | disclosed |
| US-20200339563-A1 | METHOD FOR PRODUCING TRIAZOLOPYRIDINE COMPOUND | SHIONOGI & CO., LTD. (JP) | 2020-10-29 | — | — | US | disclosed |
| EP-3546459-A1 | METHOD FOR PRODUCING TRIAZOLOPYRIDINE COMPOUND | Japan Tobacco, Inc. (JP) | 2019-10-02 | — | — | EP | disclosed |
| US-20160145254-A1 | TRIAZOLOPYRIDINE COMPOUND, AND ACTION THEREOF AS PROLYL HYDROXYLASE INHIBITOR OR ERYTHROPOIETIN PRODUCTION-INDUCING AGENT | JAPAN TOBACCO INC. (JP) | 2016-05-26 | — | — | US | disclosed |
| EP-2455381-B9 | TRIAZOLOPYRIDINE COMPOUND, AND ACTION THEREOF AS PROLYL HYDROXYLASE INHIBITOR AND ERYTHROPOIETIN PRODUCTION INDUCER | JAPAN TOBACCO INC (JP) | 2014-10-22 | — | — | EP | disclosed |
| EP-2455381-B1 | TRIAZOLOPYRIDINE COMPOUND, AND ACTION THEREOF AS PROLYL HYDROXYLASE INHIBITOR AND ERYTHROPOIETIN PRODUCTION INDUCER | JAPAN TOBACCO INC (JP) | 2014-05-28 | — | — | EP | disclosed |
| US-20130096155-A1 | TRIAZOLOPYRIDINE COMPOUND, AND ACTION THEREOF AS PROLYL HYDROXYLASE INHIBITOR OR ERYTHROPOIETIN PRODUCTION-INDUCING AGENT | JAPAN TOBACCO INC. (JP) | 2013-04-18 | — | — | US | disclosed |
| US-8283465-B2 | Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor or erythropoietin production-inducing agent | JAPAN TOBACCO INC. (JP) | 2012-10-09 | — | — | US | disclosed |
| EP-2455381-A1 | TRIAZOLOPYRIDINE COMPOUND, AND ACTION THEREOF AS PROLYL HYDROXYLASE INHIBITOR AND ERYTHROPOIETIN PRODUCTION INDUCER | Japan Tobacco, Inc. (JP) | 2012-05-23 | — | — | EP | disclosed |
| US-20110077267-A1 | TRIAZOLOPYRIDINE COMPOUND, AND ACTION THEREOF AS PROLYL HYDROXYLASE INHIBITOR OR ERYTHROPOIETIN PRODUCTION-INDUCING AGENT | JAPAN TOBACCO INC. (JP) | 2011-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200339563-A1 | METHOD FOR PRODUCING TRIAZOLOPYRIDINE COMPOUND | EPOR, PAH, THPO | EGLN1 13/4885BBOX1 2638/4885ASPH 1932/4885 |
| US-20130096155-A1 | TRIAZOLOPYRIDINE COMPOUND, AND ACTION THEREOF AS PROLYL HYDROXYLASE INHIBITOR OR ERYTHROPOIETIN PRODUCTION-INDUCING AGENT | EGLN3, EPOR, EGLN2 | EGLN1 8/4885BBOX1 1541/4885ASPH 39/4885 |
| US-11434238-B2 | Method for producing triazolopyridine compound | EPOR, PAH, THPO | EGLN1 13/4885BBOX1 2638/4885ASPH 1932/4885 |
| US-20110077267-A1 | TRIAZOLOPYRIDINE COMPOUND, AND ACTION THEREOF AS PROLYL HYDROXYLASE INHIBITOR OR ERYTHROPOIETIN PRODUCTION-INDUCING AGENT | EGLN3, EPOR, EGLN2 | EGLN1 8/4885BBOX1 1541/4885ASPH 39/4885 |
| US-20160145254-A1 | TRIAZOLOPYRIDINE COMPOUND, AND ACTION THEREOF AS PROLYL HYDROXYLASE INHIBITOR OR ERYTHROPOIETIN PRODUCTION-INDUCING AGENT | EGLN3, EPOR, EGLN2 | EGLN1 8/4885BBOX1 1541/4885ASPH 39/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.